Regeneron Math Transform Tanh Of Price Series

<div class='circular--portrait' style='background:#800000;color: #F8F8FF;font-size:4em;padding-top: 25px;;'>RP</div>
REGN -- USA Stock  

Fiscal Quarter End: 30th of June 2020  

Regeneron Pharmaceuticals math-transform tool provides you with the Math Transform execution environment for running Tanh Of Price Series transformation against Regeneron Pharmaceuticals. Analysts that use price transformation techniques rely on the belief that biggest profits from investing in Regeneron Pharmaceuticals can be made when Regeneron Pharmaceuticals shifts in price trends from positive to negative or vice versa.
Symbol
Refresh

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Regeneron Pharmaceuticals Tanh Of Price Series is a hyperbolic price transformation function. View also all equity analysis or get more info about tanh of price series math transform indicator.

Additional Technical Research

About Regeneron Pharmaceuticals Predictive Technical Analysis

The Macroaxis Predictive Technical Analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Regeneron Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Regeneron Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Regeneron Pharmaceuticals stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Regeneron Pharmaceuticals's daily price indicators and compare them against related drivers such as math transform and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Regeneron Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Regeneron Pharmaceuticals, we also check how macroeconomic factors affect Regeneron Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Earnings
Estimates (1)
LowProjected EPSHigh
23.8423.8423.84
Details
Hype
Prediction
LowEstimated ValueHigh
598.62602.70674.09
Details
Intrinsic
Valuation
LowReal ValueHigh
541.47545.55674.09
Details
Analysts
Consensus (21)
LowTarget PriceHigh
400.00557.95734.00
Details

Generate Optimal Portfolios

Align your risk and return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, take a look at Your Equity Center. Please also try Price Transformation module to use price transformation models to analyze depth of different equity instruments across global markets.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page